Home    Back

Adalimumab prn    (DrugBank: Adalimumab)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01674413
(ClinicalTrials.gov)		October 201316/8/2012Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)Calprotectin-Directed Humira® Maintenance Therapy, a Double-blind, Double-dummy, Randomized Controlled Trial in Crohn's DiseaseCrohn's DiseaseDrug: Adalimumab;Drug: Adalimumab PRN;Drug: PlaceboPeter HigginsAbbVieWithdrawn18 YearsN/AAll0Phase 3United States